Blog

Posted: 18 september 2025

Four reasons why generative AI chatbots could lead to psychosis in vulnerable people

AI developers and mental health professionals must work together to address the threat. Read more here.

Biostate AI launches AI agent that compresses research cycles from years to days

Biostate AI, a company accelerating biological research through AI models, today announced the launch of K-Dense Beta, a comprehensive multi-agent AI research system that can compress research cycles from years to days, while eliminating hallucinations that plague generative AI models.…

Doctors Who Use AI Are Viewed Worse by Peers

The research headline of the week belongs to a study out of Johns Hopkins University that found “doctors who use AI are viewed negatively by their peers. Read more here.

Sodexo extends long-term partnership with Chesterfield Royal Hospital NHS Foundation Trust

Sodexo Health & Care has strengthened its long-standing partnership with Chesterfield Royal Hospital NHS Foundation Trust after being awarded an eight-year extension to its patient dining contract, following a competitive tendering process. Read more here.

Wearable Technology Driving New Models of Care

Wearable medical devices are changing healthcare delivery by shifting care beyond traditional settings and bringing it closer to patients’ daily lives. By offering continuous monitoring, promoting patient engagement and supporting remote interventions, these technologies are becoming an essential part of…

Apple gets FDA approval for Watch hypertension feature

Apple’s latest health feature has now cleared the FDA hurdle. Hypertension notifications for Apple Watch will go live next week. Read more here.

Merck axes £1bn London research hub and cuts 125 jobs

Merck, known as MSD in Europe, will leave laboratories at the London Bioscience Innovation Centre, which hosts more than 60 life science companies, and the neighbouring Francis Crick Institute by the end of 2025. Read more here.

The Hidden Cost of Healthcare AI: Why Premium Prices Don’t Equal Premium Results

Now is a good time for health systems to step back and ask some foundational questions instead of rushing into their next AI purchase. Read more here.

Headway expands EHR with AI-assisted notes, embedded telehealth

Headway, a platform connecting patients with mental health providers covered by insurance, announced expanded EHR features for providers. Read more here.

Summit Therapeutics hits possible snag on lung cancer drug seen as a blockbuster

Summit Therapeutics may have a geography problem with its lung cancer drug ivonescimab. Ivonescimab produced weaker results in patients from North America and Europe than those from China. Read more here.

AI can evaluate social situations in a similar way to humans, offering new neuroscience research avenues

Artificial intelligence can detect and interpret social features between people from images and videos almost as reliably as humans, according to a new study from the University of Turku in Finland published in the journal Imaging Neuroscience. Read more here.

Improving outcomes following stroke through increased access to mechanical thrombectomy

More patients are getting the right treatment in the right place more quickly leading to better outcomes following a stroke thanks to a four-year collaborative programme led by Health Innovation Oxford and Thames Valley (HIOTV) supporting the deployment of artificial…

Get Involved

On the day